Companies

MedGenome buys Illumina’s Hiseq X Ten machine for genome sequencing project

Our Bureau | Updated on January 16, 2018 Published on October 07, 2016

Bengaluru-based MedGenome, a company into genomics research and diagnostics has bought the Illumina Hiseq X Ten machine, which is used for genome sequencing.

In a statement, MedGenome said that it is the first company in South-East Asia, to own one of these high throughput Illumina sequencing platforms.

Sam Santhosh, Chairman and Global CEO, MedGenome said: “We will have these machines operational in India and the US by next month and will be looking forward to collaborating with various large scale genomic projects in the region and abroad.”

The possibilities of the large scale genetic sequencing projects and genomic research that it can enable to better understand complex human diseases requires high throughput but at the same time not prohibitively expensive, point out industry watchers. The HiSeq X10 machines continue to break down barriers in traditional sequencing technologies, and in redefining the cost of whole-genome sequencing.

“The HiSeq X Ten System is the first and only platform to break the $1000 barrier for high quality human whole genome sequencing” said Tim Orpin, Vice President Asia Pacific, Illumina. Bengaluru-based genomics company MedGenome has bought the Illumina Hiseq X Ten machine, which is used for genome sequencing.

In a statement, MedGenome said that it is the first company in South-East Asia, to own one of these high throughput Illumina sequencing platforms.

Sam Santhosh, Chairman and Global CEO, MedGenome said: “We will have these machines operational in India and the US by next month and will be looking forward to collaborating with various large scale genomic projects in the region and abroad.”

The possibilities of the large scale genetic sequencing projects and genomic research that it can enable to better understand complex human diseases requires high throughput but at the same time not prohibitively expensive, point out industry watchers. The HiSeq X10 machines continue to break down barriers in traditional sequencing technologies, and in redefining the cost of whole-genome sequencing.

“The HiSeq X Ten System is the first and only platform to break the $1000 barrier for high quality human whole genome sequencing” said Tim Orpin, Vice President Asia Pacific, Illumina.

Published on October 07, 2016
This article is closed for comments.
Please Email the Editor